Literature DB >> 10382945

Chronic lymphocytic leukaemia presenting with central nervous system involvement.

L Poplawska-Szczyglowska1, J Walewski, B Pienkowska-Grela, G Rymkiewicz, O Mioduszewska.   

Abstract

A 68-year-old man presented with hemiparesis, lymphocytosis, and cerebral lesions on MRI. Flow cytometry of blood, bone marrow and cerebrospinal fluid showed B-CLL lymphocytes with bright CD20 expression, sIg, and absence of CD23 antigen. Fluorescence in situ hybridisation showed trisomy 12 in 50% of analysed peripheral mononuclear cells. The patient died 6 months after the diagnosis. Rapidly progressive and fatal course of the disease was consistent with known bad prognostic significance of CD20 bright expression and trisomy 12.

Entities:  

Mesh:

Year:  1999        PMID: 10382945     DOI: 10.1007/bf02787361

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  16 in total

Review 1.  Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia.

Authors:  S Stilgenbauer; K Döhner; M Bentz; P Lichter; H Döhner
Journal:  Ann Hematol       Date:  1998 Mar-Apr       Impact factor: 3.673

Review 2.  Cytogenetics in chronic lymphocytic leukemia.

Authors:  G Juliusson; M Merup
Journal:  Semin Oncol       Date:  1998-02       Impact factor: 4.929

3.  Meningeal involvement in leukemias and malignant lymphomas of adults: incidence, course of disease, and treatment for prevention.

Authors:  M Weizsaecker; H W Koelmel
Journal:  Acta Neurol Scand       Date:  1979-12       Impact factor: 3.209

4.  Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation.

Authors:  G Gahrton; K H Robèrt; K Friberg; L Zech; A G Bird
Journal:  Blood       Date:  1980-10       Impact factor: 22.113

5.  Richter's syndrome presenting as primary central nervous system lymphoma. Transformation of an identical clone.

Authors:  K M Bayliss; B D Kueck; C A Hanson; W G Matthaeus; U A Almagro
Journal:  Am J Clin Pathol       Date:  1990-01       Impact factor: 2.493

6.  Chronic lymphocytic leukaemia with cerebral infiltration.

Authors:  G Majumdar
Journal:  Leuk Lymphoma       Date:  1998-02

7.  Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma.

Authors:  G Juliusson; K H Robèrt; A Ost; K Friberg; P Biberfeld; B Nilsson; L Zech; G Gahrton
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

Review 8.  Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.

Authors:  S O'Brien; A del Giglio; M Keating
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

9.  Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia.

Authors:  B P O'Neill; T M Habermann; P M Banks; J R O'Fallon; J D Earle
Journal:  Cancer       Date:  1989-09-15       Impact factor: 6.860

10.  Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia.

Authors:  W G Finn; M Thangavelu; K K Yelavarthi; C L Goolsby; M S Tallman; A Traynor; L C Peterson
Journal:  Am J Clin Pathol       Date:  1996-04       Impact factor: 2.493

View more
  3 in total

1.  Leptomeningeal Carcinomatosis in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.

Authors:  Alipi V Naydenov; Lynne P Taylor
Journal:  Oncologist       Date:  2019-03-06

2.  Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review.

Authors:  Alan A Moazzam; Jan Drappatz; Ryan Y Kim; Santosh Kesari
Journal:  J Neurooncol       Date:  2011-07-17       Impact factor: 4.130

Review 3.  Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature.

Authors:  Simone Lima de Souza; Fábio Santiago; Marilza de Moura Ribeiro-Carvalho; Adriano Arnóbio; Andréa Ribeiro Soares; Maria Helena Ornellas
Journal:  BMC Res Notes       Date:  2014-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.